• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

微小 RNA-32 下调 SRC 激酶信号抑制剂 1（SRCIN1）表达促进人肝癌细胞增殖和上皮间质转化。

Downregulation of SRC Kinase Signaling Inhibitor 1 (SRCIN1) Expression by MicroRNA-32 Promotes Proliferation and Epithelial-Mesenchymal Transition in Human Liver Cancer Cells.

机构信息

Department of Infectious Diseases, Guangdong Academy of Medical Sciences, Guangdong General Hospital, Guangzhou, P.R. China.

出版信息

Oncol Res. 2018 May 7;26(4):573-579. doi: 10.3727/096504017X14954923820137. Epub 2017 May 22.

DOI:10.3727/096504017X14954923820137
PMID:28550679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7844739/
Abstract

THIS ARTICLE WAS WITHDRAWN BY THE PUBLISHER IN NOVEMBER 2020.

摘要

本文已于 2020 年 11 月由出版商撤回。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1680/7844739/6acfe9b0a63f/OR-26-573-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1680/7844739/4eafa256ab01/OR-26-573-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1680/7844739/2bb2e9f9a42b/OR-26-573-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1680/7844739/8942e53fd0ef/OR-26-573-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1680/7844739/7649d6886c25/OR-26-573-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1680/7844739/6acfe9b0a63f/OR-26-573-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1680/7844739/4eafa256ab01/OR-26-573-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1680/7844739/2bb2e9f9a42b/OR-26-573-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1680/7844739/8942e53fd0ef/OR-26-573-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1680/7844739/7649d6886c25/OR-26-573-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1680/7844739/6acfe9b0a63f/OR-26-573-g005.jpg

相似文献

1
Downregulation of SRC Kinase Signaling Inhibitor 1 (SRCIN1) Expression by MicroRNA-32 Promotes Proliferation and Epithelial-Mesenchymal Transition in Human Liver Cancer Cells.微小 RNA-32 下调 SRC 激酶信号抑制剂 1（SRCIN1）表达促进人肝癌细胞增殖和上皮间质转化。
Oncol Res. 2018 May 7;26(4):573-579. doi: 10.3727/096504017X14954923820137. Epub 2017 May 22.
2
miR-150-5p promotes the proliferation and epithelial-mesenchymal transition of cervical carcinoma cells via targeting SRCIN1.微小RNA-150-5p通过靶向SRCIN1促进宫颈癌细胞的增殖和上皮-间质转化。
Pathol Res Pract. 2019 Apr;215(4):738-747. doi: 10.1016/j.prp.2019.01.004. Epub 2019 Jan 7.
3
MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.微小RNA-451：上皮-间质转化抑制剂及肝细胞癌的预后生物标志物
Oncotarget. 2015 Jul 30;6(21):18613-30. doi: 10.18632/oncotarget.4317.
4
miR-17-5p promotes proliferation and epithelial-mesenchymal transition in human osteosarcoma cells by targeting SRC kinase signaling inhibitor 1.miR-17-5p 通过靶向 SRC 激酶信号抑制剂 1 促进人骨肉瘤细胞的增殖和上皮-间充质转化。
J Cell Biochem. 2019 Apr;120(4):5495-5504. doi: 10.1002/jcb.27832. Epub 2018 Oct 9.
5
MicroRNA-374a promotes pancreatic cancer cell proliferation and epithelial to mesenchymal transition by targeting SRCIN1.microRNA-374a 通过靶向 SRCIN1 促进胰腺癌细胞增殖和上皮间质转化。
Pathol Res Pract. 2019 Jun;215(6):152382. doi: 10.1016/j.prp.2019.03.011. Epub 2019 Mar 5.
6
Hepatitis B virus promotes proliferation and metastasis in male Chinese hepatocellular carcinoma patients through the LEF-1/miR-371a-5p/SRCIN1/pleiotrophin/Slug pathway.乙型肝炎病毒通过 LEF-1/miR-371a-5p/SRCIN1/pleiotrophin/Slug 通路促进中国男性肝癌患者的增殖和转移。
Exp Cell Res. 2018 Sep 1;370(1):174-188. doi: 10.1016/j.yexcr.2018.06.020. Epub 2018 Jun 19.
7
MicroRNA-1277 Inhibits Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells by Targeting and Suppressing BMP4 Expression and Reflects the Significant Indicative Role in Hepatocellular Carcinoma Pathology and Diagnosis After Magnetic Resonance Imaging Assessment.微小 RNA-1277 通过靶向和抑制 BMP4 表达抑制肝癌 HepG2 细胞的增殖和迁移，并在 MRI 评估后的肝癌病理学和诊断中具有重要的指示作用。
Oncol Res. 2019 Feb 21;27(3):301-309. doi: 10.3727/096504018X15213058045841. Epub 2018 Mar 21.
8
MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.微小RNA-122通过靶向Snail1和Snail2并抑制WNT/β-连环蛋白信号通路来抑制肝细胞癌中的上皮-间质转化。
Exp Cell Res. 2017 Nov 15;360(2):210-217. doi: 10.1016/j.yexcr.2017.09.010. Epub 2017 Sep 8.
9
PNMA1, regulated by miR-33a-5p, promotes proliferation and EMT in hepatocellular carcinoma by activating the Wnt/β-catenin pathway.PNMA1 通过激活 Wnt/β-catenin 通路促进肝癌的增殖和 EMT，受 miR-33a-5p 的调控。
Biomed Pharmacother. 2018 Dec;108:492-499. doi: 10.1016/j.biopha.2018.09.059. Epub 2018 Sep 19.
10
Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma.与Twist1相关的miR-26b-5p通过靶向SMAD1抑制肝细胞癌中的上皮-间质转化、迁移和侵袭。
Oncotarget. 2016 Apr 26;7(17):24383-401. doi: 10.18632/oncotarget.8328.

引用本文的文献

1
The p140Cap adaptor protein as a molecular hub to block cancer aggressiveness.p140Cap 衔接蛋白作为一个分子枢纽来阻断癌症侵袭性。
Cell Mol Life Sci. 2021 Feb;78(4):1355-1367. doi: 10.1007/s00018-020-03666-w. Epub 2020 Oct 20.
2
SRCIN1 Regulated by circCCDC66/miR-211 Is Upregulated and Promotes Cell Proliferation in Non-Small-Cell Lung Cancer.SRCIN1 受 circCCDC66/miR-211 调控，在非小细胞肺癌中上调并促进细胞增殖。
Biomed Res Int. 2020 Sep 9;2020:5307641. doi: 10.1155/2020/5307641. eCollection 2020.
3
lncRNA TPTEP1 competitively sponges miR‑328‑5p to inhibit the proliferation of non‑small cell lung cancer cells.

本文引用的文献

1
Colorectal cancer characterization and therapeutic target prediction based on microRNA expression profile.基于微小RNA表达谱的结直肠癌特征分析与治疗靶点预测
Sci Rep. 2016 Feb 8;6:20616. doi: 10.1038/srep20616.
2
Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53.肿瘤抑制因子p53对癌症干细胞标志物CD133的转录抑制作用。
Cell Death Dis. 2015 Nov 5;6(11):e1964. doi: 10.1038/cddis.2015.313.
3
Regulation of MicroRNA 183 by Cyclooxygenase 2 in Liver Is DEAD-Box Helicase p68 (DDX5) Dependent: Role in Insulin Signaling.
lncRNA TPTEP1 通过竞争性吸附 miR-328-5p 抑制非小细胞肺癌细胞的增殖。
Oncol Rep. 2020 May;43(5):1606-1618. doi: 10.3892/or.2020.7522. Epub 2020 Feb 26.
4
MicroRNA-665 promotes the proliferation of ovarian cancer cells by targeting SRCIN1.微小RNA-665通过靶向SRCIN1促进卵巢癌细胞的增殖。
Exp Ther Med. 2020 Feb;19(2):1112-1120. doi: 10.3892/etm.2019.8293. Epub 2019 Dec 5.
5
miR-30a-3p inhibits the proliferation of liver cancer cells by targeting DNMT3a through the PI3K/AKT signaling pathway.微小RNA-30a-3p通过PI3K/AKT信号通路靶向DNA甲基转移酶3a来抑制肝癌细胞的增殖。
Oncol Lett. 2020 Jan;19(1):606-614. doi: 10.3892/ol.2019.11179. Epub 2019 Dec 3.
6
MicroRNA‑208a directly targets Src kinase signaling inhibitor 1 to facilitate cell proliferation and invasion in non‑small cell lung cancer.微小 RNA-208a 通过靶向Src 激酶信号抑制剂 1 促进非小细胞肺癌细胞的增殖和侵袭。
Mol Med Rep. 2019 Oct;20(4):3140-3148. doi: 10.3892/mmr.2019.10542. Epub 2019 Jul 31.
7
Role of microRNA-150-5p/SRCIN1 axis in the progression of breast cancer.微小RNA-150-5p/SRCIN1轴在乳腺癌进展中的作用。
Exp Ther Med. 2019 Mar;17(3):2221-2229. doi: 10.3892/etm.2019.7206. Epub 2019 Jan 28.
8
Hypoxia and Selective Autophagy in Cancer Development and Therapy.癌症发展与治疗中的缺氧和选择性自噬
Front Cell Dev Biol. 2018 Sep 10;6:104. doi: 10.3389/fcell.2018.00104. eCollection 2018.
9
Hierarchical structural component modeling of microRNA-mRNA integration analysis.miRNA-mRNA 整合分析的层次结构组件建模。
BMC Bioinformatics. 2018 May 8;19(Suppl 4):75. doi: 10.1186/s12859-018-2070-0.
肝脏中环氧合酶2对微小RNA 183的调控依赖于DEAD盒解旋酶p68（DDX5）：在胰岛素信号传导中的作用
Mol Cell Biol. 2015 Jul;35(14):2554-67. doi: 10.1128/MCB.00198-15. Epub 2015 May 11.
4
Global cancer statistics, 2012.全球癌症统计数据，2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
5
miR-183 inhibits invasion of gastric cancer by targeting Ezrin.微小RNA-183通过靶向埃兹蛋白抑制胃癌侵袭。
Int J Clin Exp Pathol. 2014 Aug 15;7(9):5582-94. eCollection 2014.
6
miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1.miR-150 通过调控 GAB1 和 FOXP1 的表达影响慢性淋巴细胞白血病中 B 细胞受体信号转导。
Blood. 2014 Jul 3;124(1):84-95. doi: 10.1182/blood-2013-09-527234. Epub 2014 May 1.
7
Identification of two regions in the p140Cap adaptor protein that retain the ability to suppress tumor cell properties.鉴定衔接蛋白 p140Cap 中保留抑制肿瘤细胞特性能力的两个区域。
Am J Cancer Res. 2013 Jun 20;3(3):290-301. Print 2013.
8
The role of microRNAs in colorectal cancer.微小 RNA 在结直肠癌中的作用。
Cancer J. 2012 May-Jun;18(3):244-52. doi: 10.1097/PPO.0b013e318258b78f.
9
p140Cap suppresses the invasive properties of highly metastatic MTLn3-EGFR cells via impaired cortactin phosphorylation.p140Cap 通过抑制 cortactin 的磷酸化来抑制高转移性 MTLn3-EGFR 细胞的侵袭特性。
Oncogene. 2012 Feb 2;31(5):624-33. doi: 10.1038/onc.2011.257. Epub 2011 Jul 4.
10
Rho kinase phosphorylation promotes ezrin-mediated metastasis in hepatocellular carcinoma.Rho 激酶磷酸化促进肝癌中 ezrin 介导的转移。
Cancer Res. 2011 Mar 1;71(5):1721-9. doi: 10.1158/0008-5472.CAN-09-4683.